6N3-29246-68215
4 vaccinations
14 coded responses
37 check-ins
14 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 483 / MI
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain, Musculoskeletal stiffness — Feeling: Good · Muscle or body achesFree text: Still some soreness and muscle stiffness near injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-12
- 2021-03-13
-
2021-03-14
Survey response — day 7, dose 1MedDRA: Epistaxis, Rash macular, Self-medication — Feeling: Good · Site: Redness · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Local red blotch on hand after minor scrape (uncharacteristic reaction for me) and unprovoked vigorous nosebleed, stopped after 20 minutes of packing, compression, and decongestant sprayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
-
2021-03-28
Dose 2 — Pfizer-BioNTech
-
2021-03-28
Survey response — day 0, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: Still having more nosebleeds than usual after 1st shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 2MedDRA: Epistaxis — Feeling: Good · Site: PainFree text: Unprompted nosebleedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Epistaxis, Rash, Vaccine positive rechallenge — Feeling: Good · Site: Pain, Redness · Headache, Muscle or body achesFree text: Getting some temporary red blotches on forehead that go away after a few hours. Noticed after first shot too. Also nosebleeds.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Epistaxis — Feeling: GoodFree text: NosebleedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site pain — Feeling: Good · Site: PainFree text: Still slight redness, soreness at injection site. But less soreness than after first shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue — Feeling: GoodFree text: Plenty of sleep but still tired, fatigued with exertionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — day 7, dose 2MedDRA: Epistaxis — Feeling: GoodFree text: NosebleedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
-
2021-04-18
Survey response — day 21, dose 2MedDRA: Epistaxis, Memory impairment, Sinus congestion — Feeling: FairFree text: A couple severe nosebleeds that took more than 45 minutes to get under control. Some sinus congestion. Increased forgetfulness.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — day 28, dose 2MedDRA: Epistaxis, Fatigue — Feeling: FairFree text: Having more fatigue. Also harder to stop nose bleeds.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-02
- 2021-05-10
-
2021-09-03
Dose 3 — Pfizer-BioNTech
-
2021-09-04
Survey response — days 1–6 daily, dose 3MedDRA: Epistaxis — Feeling: Fair · Site: Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Vigorous nosebleed, used nasal decongestant spray, BleedCease packing, and compression to staunch flow.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-09-07
- 2021-09-08
- 2021-09-09
-
2021-09-10
Survey response — day 7, dose 3MedDRA: Epistaxis — Feeling: Good · Headache, Fatigue or tirednessFree text: Still having nosebleeds.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-18
- 2021-09-24
- 2021-10-01
- 2021-10-08
-
2021-10-15
Survey response — day 42, dose 3MedDRA: Headache, Unevaluable event — Feeling: GoodFree text: Mild headaches occasionally in spite of being well hydrated.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-03
- 2022-03-04
-
2022-03-25
Dose 4 — Pfizer-BioNTech
- 2022-06-26
- 2022-09-25
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-28 | Pfizer-BioNTech | |
| 3 | 2021-09-03 | Pfizer-BioNTech | No |
| 4 | 2022-03-25 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Still some soreness and muscle stiffness near injection site
Release 5 — day 7, dose 1
Systemic reaction (other): Local red blotch on hand after minor scrape (uncharacteristic reaction for me) and unprovoked vigorous nosebleed, stopped after 20 minutes of packing, compression, and decongestant spray
Release 6 — day 0, dose 2
Systemic reaction (other): Still having more nosebleeds than usual after 1st shot
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Unprompted nosebleed
Systemic reaction (other): Getting some temporary red blotches on forehead that go away after a few hours. Noticed after first shot too. Also nosebleeds.
Systemic reaction (other): Nosebleed
Systemic reaction (other): Still slight redness, soreness at injection site. But less soreness than after first shot.
Systemic reaction (other): Plenty of sleep but still tired, fatigued with exertion
Release 6 — day 7, dose 2
Systemic reaction (other): Nosebleed
Release 7 — day 21, dose 2
Symptoms: A couple severe nosebleeds that took more than 45 minutes to get under control. Some sinus congestion. Increased forgetfulness.
Release 7 — day 28, dose 2
Symptoms: Having more fatigue. Also harder to stop nose bleeds.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Vigorous nosebleed, used nasal decongestant spray, BleedCease packing, and compression to staunch flow.
Release 9 — day 7, dose 3
Systemic reaction (other): Still having nosebleeds.
Release 10 — day 42, dose 3
Symptoms: Mild headaches occasionally in spite of being well hydrated.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Epistaxis | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Memory impairment | ✓ | ✓ | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Epistaxis | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash macular | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Vaccine positive rechallenge | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release